SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Techera Engineering India Ltd

Industry : Engineering

BSE Code

ISIN Demat

Book Value()

92971

INE0JQS01019

30.0419165

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

TECHERA

101.46

321.83

EPS(TTM)

Face Value()

Div & Yield %

1.92

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter

Nov 06,2025

Net profit of Glaxosmithkline Pharmaceuticals rose 1.98% to Rs 257.49 crore in the quarter ended September 2025 as against Rs 252.50 crore during the previous quarter ended September 2024. Sales declined 3.05% to Rs 979.94 crore in the quarter ended September 2025 as against Rs 1010.77 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	979.94	1010.77	-3
OPM %	34.26	31.83	-
PBDT	368.79	355.98	4
PBT	351.36	339.12	4
NP	257.49	252.50	2

73,319.55 185.23 ( 0.25%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)